Skip to main content
. 2016 Feb 5;7(5):490–499. doi: 10.7150/jca.12351

Figure 2.

Figure 2

ROC analyses for distinguishing cancer from normal controls and benign lesions in LuCa, BrCa and CRC using miR-21 and miR-152. (a) miR-21 for LuCa vs. normal, (b) miR-152 for LuCa vs. normal, (c) miR-21 for BrCa vs. normal, (d) miR-152 for BrCa vs. normal, (e) miR-152 for CRC vs. normal, and (f) miR-152 for CRC vs. polyps.